BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 35536416)

  • 21. Serum FGF23 levels in normal and disordered phosphorus homeostasis.
    Weber TJ; Liu S; Indridason OS; Quarles LD
    J Bone Miner Res; 2003 Jul; 18(7):1227-34. PubMed ID: 12854832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Osteocytes and the pathogenesis of hypophosphatemic rickets.
    Yamazaki M; Michigami T
    Front Endocrinol (Lausanne); 2022; 13():1005189. PubMed ID: 36246908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FGF23-FGF Receptor/Klotho Pathway as a New Drug Target for Disorders of Bone and Mineral Metabolism.
    Fukumoto S
    Calcif Tissue Int; 2016 Apr; 98(4):334-40. PubMed ID: 26126937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical aspect of recent progress in phosphate metabolism. Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23)].
    Endo I
    Clin Calcium; 2009 Jun; 19(6):815-20. PubMed ID: 19483276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Phosphatonin].
    Endo I; Matsumoto T
    Clin Calcium; 2007 Oct; 17(10):1580-4. PubMed ID: 17906412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The skeleton: endocrine regulator of phosphate homeostasis.
    Doyle ME; Jan de Beur SM
    Curr Osteoporos Rep; 2008 Dec; 6(4):134-41. PubMed ID: 19032923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of phosphate homeostasis by the phosphatonins and other novel mediators.
    Shaikh A; Berndt T; Kumar R
    Pediatr Nephrol; 2008 Aug; 23(8):1203-10. PubMed ID: 18288501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Disorders of phosphate metabolism].
    Fukumoto S
    Rinsho Byori; 2010 Mar; 58(3):225-31. PubMed ID: 20408440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Osteo-renal cross-talk and phosphate metabolism by the FGF23-Klotho system.
    Ohnishi M; Razzaque MS
    Contrib Nephrol; 2013; 180():1-13. PubMed ID: 23652546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Bone and joint diseases in children. Phosphaturic hormone, FGF23, and bone metabolism].
    Ozono K
    Clin Calcium; 2010 Jun; 20(6):896-903. PubMed ID: 20513948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. X-Linked Hypophosphatemia and FGF23-Related Hypophosphatemic Diseases: Prospect for New Treatment.
    Kinoshita Y; Fukumoto S
    Endocr Rev; 2018 Jun; 39(3):274-291. PubMed ID: 29381780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of phosphate homeostasis in infants, children, and adolescents, and the role of phosphatonins in this process.
    Garabedian M
    Curr Opin Pediatr; 2007 Aug; 19(4):488-91. PubMed ID: 17630616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phosphate homeostasis and genetic mutations of familial hypophosphatemic rickets.
    Razali NN; Hwu TT; Thilakavathy K
    J Pediatr Endocrinol Metab; 2015 Sep; 28(9-10):1009-17. PubMed ID: 25894638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endocrine functions of bone in mineral metabolism regulation.
    Quarles LD
    J Clin Invest; 2008 Dec; 118(12):3820-8. PubMed ID: 19033649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New Therapies for Hypophosphatemia-Related to FGF23 Excess.
    Athonvarangkul D; Insogna KL
    Calcif Tissue Int; 2021 Jan; 108(1):143-157. PubMed ID: 32504139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice.
    Sitara D; Razzaque MS; Hesse M; Yoganathan S; Taguchi T; Erben RG; Jüppner H; Lanske B
    Matrix Biol; 2004 Nov; 23(7):421-32. PubMed ID: 15579309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibroblast growth factor 23 as a phosphotropic hormone and beyond.
    Fukumoto S; Shimizu Y
    J Bone Miner Metab; 2011 Sep; 29(5):507-14. PubMed ID: 21822586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular Control of Phosphorus Homeostasis and Precision Treatment of Hypophosphatemic Disorders.
    Weber TJ; Quarles LD
    Curr Mol Biol Rep; 2019 Jun; 5(2):75-85. PubMed ID: 31871877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mineralized tissues in hypophosphatemic rickets.
    Robinson ME; AlQuorain H; Murshed M; Rauch F
    Pediatr Nephrol; 2020 Oct; 35(10):1843-1854. PubMed ID: 31392510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FGF23 in skeletal modeling and remodeling.
    Lu Y; Feng JQ
    Curr Osteoporos Rep; 2011 Jun; 9(2):103-8. PubMed ID: 21404002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.